BMIYX
Price
$7.39
Change
+$0.04 (+0.54%)
Updated
Jul 3 closing price
Net Assets
176.14M
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

BMIYX vs VVIAX

Header iconBMIYX vs VVIAX Comparison
Open Charts BMIYX vs VVIAXBanner chart's image
BNY Mellon Income Stock Y
Price$7.39
Change+$0.04 (+0.54%)
VolumeN/A
Net Assets176.14M
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
BMIYX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BMIYX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMIYX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. BMIYX (176M). VVIAX pays higher dividends than BMIYX: VVIAX (2.18) vs BMIYX (1.47). BMIYX was incepted earlier than VVIAX: BMIYX (9 years) vs VVIAX (25 years). BMIYX (0.93) is less costly to investors than VVIAX (0.05). BMIYX is a more actively managed with annual turnover of: 92.12 vs. VVIAX (9.00). VVIAX has a lower initial minimum investment than BMIYX: VVIAX (3000) vs BMIYX (1000000). VVIAX annual gain was more profitable for investors over the last year : 12.03 vs. BMIYX (-1.76). VVIAX return over 5 years is better than : 80.13 vs. BMIYX (15.36).
BMIYXVVIAXBMIYX / VVIAX
Total Expense Ratio0.900.051,800%
Annual Report Gross Expense Ratio0.930.051,860%
Fund Existence9 years25 years-
Gain YTD9.8666.198159%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets176M189B0%
Annual Yield % from dividends1.472.1868%
Returns for 1 year-1.7612.03-15%
Returns for 3 years-10.8435.17-31%
Returns for 5 years15.3680.1319%
Returns for 10 yearsN/A115.67-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.